ERBE Elektromedizin GmbH
ERBE Elektromedizin GmbH, headquartered in Tübingen, Germany, is a leading innovator in the medical technology industry, specialising in high-frequency surgical equipment and devices. Founded in 1851, the company has established a strong presence in Europe and beyond, focusing on areas such as electrosurgery, laser therapy, and endoscopy. With a commitment to advancing surgical techniques, ERBE offers a range of core products, including the renowned VIO® electrosurgical generator and the ICC® plasma coagulation system, which are distinguished by their precision and reliability. The company has achieved significant milestones, including numerous patents and awards, solidifying its position as a trusted partner in healthcare. ERBE Elektromedizin continues to lead the market with innovative solutions that enhance surgical outcomes and improve patient safety.
DitchCarbon Score
How does ERBE Elektromedizin GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ERBE Elektromedizin GmbH's score of 19 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
ERBE Elektromedizin GmbH's reported carbon emissions
In 2022, ERBE Elektromedizin GmbH reported total carbon emissions of approximately 88,005,000 kg CO2e. This figure includes 1,608,000 kg CO2e from Scope 1 emissions and no reported Scope 2 emissions, while a significant portion, about 86,397,000 kg CO2e, falls under Scope 3 emissions. Comparatively, in 2019, the company had total emissions of about 73,781,000 kg CO2e, with Scope 1 emissions at 1,798,000 kg CO2e, Scope 2 emissions at 946,000 kg CO2e, and Scope 3 emissions accounting for approximately 71,036,000 kg CO2e. Despite the increase in total emissions from 2019 to 2022, ERBE Elektromedizin GmbH has not publicly disclosed specific reduction targets or initiatives aimed at mitigating their carbon footprint. The absence of defined climate pledges or science-based targets suggests a need for further commitment to sustainability practices within the industry context. Overall, ERBE Elektromedizin GmbH's emissions profile highlights the importance of addressing Scope 3 emissions, which represent the majority of their carbon footprint, as part of their climate strategy moving forward.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2022 | |
|---|---|---|
| Scope 1 | 1,798,000 | 0,000,000 |
| Scope 2 | 946,000 | - |
| Scope 3 | 71,036,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
ERBE Elektromedizin GmbH is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
